Sherbrooke Park Advisers LLC Editas Medicine, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 15,024 shares of EDIT stock, worth $28,846. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,024
Previous 77,663
80.65%
Holding current value
$28,846
Previous $265 Million
92.8%
% of portfolio
0.01%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding EDIT
# of Institutions
225Shares Held
54.2MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$14.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$13.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$5.27 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$4.15 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$3.59 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $132M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...